Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2019 | 03-2018 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -28,599 | N/A | N/A | N/A |
| Depreciation Amortization | 10 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -882 | N/A | N/A | N/A |
| Other Working Capital | -1,451 | N/A | N/A | N/A |
| Other Operating Activity | 2,375 | 0 | 0 | 0 |
| Operating Cash Flow | $-28,547 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -52 | N/A | N/A | N/A |
| Investing Cash Flow | $-52 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 14,910 | N/A | N/A | N/A |
| Other Financing Activity | 20,674 | 0 | 0 | 0 |
| Financing Cash Flow | $35,584 | $N/A | $N/A | $N/A |
| End Cash Position | 6,985 | N/A | N/A | N/A |
| Net Cash Flow | $6,985 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -28,547 | N/A | N/A | N/A |
| Capital Expenditure | -52 | N/A | N/A | N/A |
| Free Cash Flow | -28,599 | 0 | 0 | 0 |